Northland Capital Markets Upgrades Edwards Lifesciences (EW) to Outperform
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $86.96 +1.19%
Rating Summary:
23 Buy, 18 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 8 | New: 36
Rating Summary:
23 Buy, 18 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 8 | New: 36
Join SI Premium – FREE
Northland Capital Markets upgraded Edwards Lifesciences (NYSE: EW) from Market Perform to Outperform with a price target of $105.00.
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $91.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Upgrades Galp Energia (GALP:SM) (GLPEY) to Equalweight
- JPMorgan Upgrades Assai Atacadista (ASAI) to Overweight
- Piper Sandler Upgrades BlackLine (BL) to Neutral
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
